Pineapple Energy Announces Corporate Name Change to SUNation Energy, Inc., and New Ticker Symbol
New Ticker Symbol “SUNE” Effective November 19TH, 2024 Reincorporation to Delaware Effective November 14TH, 2024 RONKONKOMA, N.Y., Nov. 18, 2024 […]
Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders
Dual-action approach combining 5-HT4R Agonist (SPC-15) and NMDAR antagonist demonstrates enhanced efficacy in preclinical study for managing severe conditions The […]
Phunware to Participate in the 13th Annual ROTH Technology Conference in New York City November 20, 2024
AUSTIN, Texas, Nov. 18, 2024 (GLOBE NEWSWIRE) — Phunware, Inc. (“Phunware” or the “Company”) (NASDAQ: PHUN), a leader in enterprise […]
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter
FLORHAM PARK, N.J., Nov. 18, 2024 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, […]
Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer
Ms. Nassif brings an extensive track record of successfully developing commercial strategies for multiple FDA-approved drugs Appointment initiates Cassava’s commercial […]
Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Actively Exploring Partnership for Alzheimer’s DevelopmentSupplementary Financing Concluded in Q4 ROCHESTER, N.Y., Nov. 18, 2024 (GLOBE NEWSWIRE) — Vaccinex, Inc. […]
Newtek Bank, N.A. Launches Newtek Zero-Fee Business Banking™
BOCA RATON, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) — NewtekOne, Inc. (NASDAQ: NEWT) announced today that its national bank subsidiary, […]
AmpliTech Group’s AmpliTech Inc. Division Secures Initial Purchase Order Under 5-Year Basic Order Agreement With Fortune 1000 U.S. Company
HAUPPAUGE, N.Y., Nov. 18, 2024 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of […]
ECD Auto Design Announces Addition of Chief Revenue Officer Kevin Kastner
KISSIMMEE, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) — ECD Automotive Design, Inc. (Nasdaq: ECDA) (“ECA Auto Design” or the “Company”), […]
Allogene Therapeutics Presents Preclinical Data for ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Disease at the American College of Rheumatology (ACR) Convergence
ALLO-329 Induces Deep, Transient Depletion of CD19+ B Cells and CD70+ T Cells, and Reduction in IgG and IgM without […]
